thomas schael - eye for pharma berlin 2013: a regional payers’ perspective of the explanation of...

14
A Regional Payers' Perspective of the Explanation of the Italian System from AIFA to local hospitals Thomas Schael CEO ASL Magna Grecia Crotone - Commissionar ASL Napoli 2 Nord Coordinator Pharmaclick Punto Salute Advisor Healthcare Reform Regione Piemonte Berlin, October 22 nd 2013

Upload: thomas-schael

Post on 29-Nov-2014

698 views

Category:

Health & Medicine


0 download

DESCRIPTION

Thomas Schael's presentation on insights and actionables on drug expenditure and the requirements of Italian payers for market access at the Payers' Forum Europe 2013 in Berlin.Thomas Schael discusses Italy’s drug distribution system and explains how he dramatically cut spending on drugs. Schael gives his outlook on the major challenges for drug expenditure in Italy and Europe and offers advice to the pharmaceutical industry on how to work better with authorities.

TRANSCRIPT

Page 1: Thomas Schael - Eye for Pharma Berlin 2013: A regional payers’ perspective of the explanation of the Italian pharmaceutical system and supply chain from AIFA to Local Health Authorities

A Regional Payers' Perspective

of the Explanation of the Italian System from

AIFA to local hospitals

Thomas Schael CEO ASL Magna Grecia Crotone - Commissionar ASL Napoli 2 Nord

Coordinator Pharmaclick Punto Salute

Advisor Healthcare Reform Regione Piemonte

Berlin, October 22nd 2013

Page 2: Thomas Schael - Eye for Pharma Berlin 2013: A regional payers’ perspective of the explanation of the Italian pharmaceutical system and supply chain from AIFA to Local Health Authorities

Spending review 2010 (D.L. 78/2010):

Impact of 1,3 billion €

(Source: estimates IMS Health)

Page 3: Thomas Schael - Eye for Pharma Berlin 2013: A regional payers’ perspective of the explanation of the Italian pharmaceutical system and supply chain from AIFA to Local Health Authorities

3

A very complex Supply Chain

Page 4: Thomas Schael - Eye for Pharma Berlin 2013: A regional payers’ perspective of the explanation of the Italian pharmaceutical system and supply chain from AIFA to Local Health Authorities

4

Farmaceutica convenzionata

conventional distribution by local pharmacies with a reimbursement

contract referring to official AIFA prices with a possible discount

Distribuzione diretta

direct distribution of pharmaceuticals by public health authorities and

hospitals bought directly from the producer

Distribuzione in nome e per conto

distribution of pharmaceuticals by local pharmacies bought directly from

the producer by local health authorities paying a fixed service fee for each

unit distributed by the pharmacies

New models for the distribution of pharmaceuticals in Italy

Page 5: Thomas Schael - Eye for Pharma Berlin 2013: A regional payers’ perspective of the explanation of the Italian pharmaceutical system and supply chain from AIFA to Local Health Authorities

The Public Health Authority Province of Naples

“ASL Napoli 2 Nord”

•Over 1 million inhabitants

•32 Cities and the Irlands of

Ischia and Procida

•Territorry of 450 square km

•5 public hospitals and

5 private hospitals

•4200 employees and 1800

contracted GPs

Page 6: Thomas Schael - Eye for Pharma Berlin 2013: A regional payers’ perspective of the explanation of the Italian pharmaceutical system and supply chain from AIFA to Local Health Authorities

ASL Napoli 2 Nord: 223 privat pharmacies

Page 7: Thomas Schael - Eye for Pharma Berlin 2013: A regional payers’ perspective of the explanation of the Italian pharmaceutical system and supply chain from AIFA to Local Health Authorities

ASL Napoli 2 Nord: public pharmacies and hospitals

10 Farmacia distrettuale

4 Farmacia ospedaliera

Page 8: Thomas Schael - Eye for Pharma Berlin 2013: A regional payers’ perspective of the explanation of the Italian pharmaceutical system and supply chain from AIFA to Local Health Authorities

Project

A.R.Ca.

Pharmaceutical spending control project

Page 10: Thomas Schael - Eye for Pharma Berlin 2013: A regional payers’ perspective of the explanation of the Italian pharmaceutical system and supply chain from AIFA to Local Health Authorities

The people involved

10

Page 11: Thomas Schael - Eye for Pharma Berlin 2013: A regional payers’ perspective of the explanation of the Italian pharmaceutical system and supply chain from AIFA to Local Health Authorities

Ipertension (C09)

% ddd Losartan 2010 ASL Napoli 2 Nord

Page 12: Thomas Schael - Eye for Pharma Berlin 2013: A regional payers’ perspective of the explanation of the Italian pharmaceutical system and supply chain from AIFA to Local Health Authorities

ASL Napoli 2 Nord

usage of Losartan in different districts in 2010

Page 13: Thomas Schael - Eye for Pharma Berlin 2013: A regional payers’ perspective of the explanation of the Italian pharmaceutical system and supply chain from AIFA to Local Health Authorities

Reduction of the pharmceutical spending

ASL Napoli 2 Nord 2010

-€ 20 milioni in 9 months

-€ 40 per citizen per year

Page 14: Thomas Schael - Eye for Pharma Berlin 2013: A regional payers’ perspective of the explanation of the Italian pharmaceutical system and supply chain from AIFA to Local Health Authorities

= 14%

Next challenge: Regione Piemonte

Source: AIFA Rapporto OSMED gennaio-Settembre 2012

Objectives

- 10% spending on territorial pharma - 5% spending on hospital pharma

Cost Earnings - €96 million

Period 2013-2015